Aug 29, 2023 | Infection Control, News
Vaxess Technologies, Inc., a life sciences company developing a shelf-stable vaccine patch with potential for self-application, announced that it is collaborating with AstraZeneca for the evaluation of an RNA-based pandemic influenza prototype vaccine in patch format.... 
Aug 22, 2023 | Infection Control, News
The US Food and Drug Administration approved Abrysvo (Respiratory Syncytial Virus Vaccine), the first vaccine approved for use in pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in... 
Aug 9, 2023 | Covid-19, News
CREDIT: NIH/NIAID cc A fourth dose of the bivalent (two-strain) COVID-19 vaccine is substantially more effective against medical treatment and hospitalization than a fourth monovalent (single-strain) dose among both previously infected and never-infected people who... 
Jul 26, 2023 | Covid-19, Infection Control, News
A new paper in Biology Methods & Protocols, published by Oxford University Press, shows it may be possible to design vaccines that will induce a stronger immune response to infecting pathogens, such as the virus causing COVID-19. In this study, the authors...
